Effectiveness and Implementation of a Clinical Risk Score for Early Diagnosis of Tuberculosis in Uganda: A Pragmatic, Clustered Randomization Clinical Trial

临床风险评分在乌干达结核病早期诊断中的有效性和实施情况:一项实用性整群随机临床试验

阅读:4

Abstract

Rationale: Undertreatment of tuberculosis (TB) is common in resource-limited settings where same-day microbiological diagnosis is unavailable. Objectives: We evaluated if a simple clinical risk score for predicting active TB could facilitate treatment initiation among individuals at high risk for TB. Methods: We conducted a pragmatic, implementation-effectiveness study in periurban primary health clinics in Uganda. Four intervention clinics were paired with standard-of-care comparison clinics. Providers in intervention clinics were trained to use the score and set a threshold score for considering same-day treatment initiation; treatment decisions were at the providers' discretion. Our primary effectiveness outcome was the change in the proportion of individuals with confirmed TB who started on treatment within 7 days of presentation, comparing preintervention and postintervention periods. Results: Among intervention clinics, 594 (83%) of 720 people diagnosed with TB started treatment within 7 days during the preintervention period versus 264 (84%) of 316 after implementation (pre-post difference, 1%; 95% confidence interval [95% CI], -6%, 8%). In comparison clinics, 7-day treatment initiation changed from 312 (86%) of 363 preintervention to 153 (73%) of 211 postintervention (pre-post difference, -13%; 95% CI, -22, -5%). A difference-in-differences estimate was 14% (95% CI, 10%, 19%). In intervention clinics, 1,206 (66%) of 1,826 people presenting with TB symptoms were administered the risk score. Two hundred twenty-nine (19%) had a score above the treatment threshold, and 105 (46%) initiated treatment on the same day. Conclusions: An easy-to-use clinical risk score did not increase 7-day empiric treatment initiation in intervention clinics. However, it improved rapid treatment initiation relative to clinics using the prevailing standard of care. The score was also highly acceptable to clinical providers. Clinical trial registered with www.clinicaltrials.gov (NCT05122624).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。